IP Library Granted Patent US 10,100,347
Granted Patent B2
US 10,100,347 · App. 15/139,318 · Granted Oct 16, 2018

Mapping cell identity determinants in chromatin

Inventors: Zbyszek Otwinowski (Dallas, TX); Dominika Borek (Dallas, TX)
Assignee: Board of Regents, The University of Texas System
C12Q1/6806C12Q1/6855C12Q1/6869
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,100,347
App. No.
15/139,318
Granted
Oct 16, 2018
Kind
B2
Abstract

The invention provides materials and methods to identify and analyze in a genome-wide manner the structural determinants of this organization. Next generation sequencing methods, combined with a novel assay and integrated data analysis, are used to map the long-range interactions in chromatin that are involved in the regulation of transcription.

Claims (17)

1. A method for processing DNA fragments, comprising:

ligating in a single reaction dN-tailed, cross-linked DNA fragments to four duplex adapters: R1 and R2 recombination adapters and S1 and S2 sequencing adapters, wherein the recombination adapters each contain a site-specific recombinase target site and R1 contains an affinity tag.

2. The method of claim 1 further comprising subsequent steps of:

recombining the target sites with a corresponding site-specific recombinase;

isolating recombined fragments comprising the affinity tag;

amplifying by PCR the recombined fragments comprising the affinity tag with primers complementary to the sequencing adapters; and

sequencing the amplified PCR product.

3. The method of claim 1 further comprising antecedent steps of:

fragmenting cross-linked chromatin into 300-600 bp fragments; and

blunt ending and dN tailing the fragments.

4. The method of claim 1 further comprising antecedent steps of:

fragmenting cross-linked chromatin into 300-600 bp fragments; and

blunt ending and dN tailing the fragments; and subsequent steps of:

recombining the target sites with a corresponding site-specific recombinase;

isolating recombined fragments comprising the affinity tag;

amplifying by PCR the recombined fragments comprising the affinity tag with primers complementary to the sequencing adapters; and

sequencing the amplified PCR product.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 29, 2016
From: OTWINOWSKI, ZBYSZEK; BOREK, DOMINIKA
To: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
Reel/Frame 038415/0693 →
Continuity (2)
Provisional Application 62152926 · Apr 26, 2015
Related Publication 20160312267A1 · Oct 27, 2016
Cited By (1)
US 12,573,039